Hemoadsorption reprograms inflammation in experimental gram-negative septic peritonitis: Insights from in vivo and in Silico studies

Molecular Medicine

Volumn 18, Issue 10, 2012, Pages 1366-1374

  Namas, Rami A ^a,b   Namas, Rajaie ^a,c   Lagoa, Claudio ^a   Barclay, Derek ^a   Mi, Qi ^a,b,c   Zamora, Ruben ^a,b   Peng, Zhiyong ^a,d   Wen, Xiaoyan ^a,d   Fedorchak, Morgan V ^a,b   Valenti, Isabella E ^a,b   Federspiel, William J ^a,b,d,e   Kellum, John A ^a,b,d   Vodovotz, Yoram ^a,b  

^a Department of Surgery ^*  (United States)

^b MCGOWAN INSTITUTE FOR REGENERATIVE MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^e University of Pittsburgh   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; CXCL1 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 5; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NITROGEN DIOXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL COUNT; BACTERIAL PERITONITIS; BLOOD SAMPLING; CONTROLLED STUDY; CYTOKINE RESPONSE; ESCHERICHIA COLI INFECTION; FIBRIN CLOT; GRAM NEGATIVE SEPSIS; HEMADSORPTION; HEMODIALYSIS; IMMUNOMODULATION; LIVER INJURY; MALE; NONHUMAN; PERITONEAL FLUID LEVEL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TREATMENT OUTCOME; UPREGULATION;

ADSORPTION; ANIMALS; BIOLOGICAL MARKERS; COLONY COUNT, MICROBIAL; COMPUTATIONAL BIOLOGY; ESCHERICHIA COLI; FIBRIN; HEMOFILTRATION; INFLAMMATION; INFLAMMATION MEDIATORS; LIVER; MALE; PERITONEUM; PERITONITIS; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS;

EID: 84870827578     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2012.00106     Document Type: Article

References (38)

1. Abraham E, Singer M. (2007) Mechanisms of sepsis-induced organ dysfunction. Crit. Care Med. 35:2408-16.
2. Kellum JA, et al. (2007) Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch. Intern. Med. 167:1655-63.
3. Namas R, et al. (2012) Sepsis: something old, something new, and a systems view. J. Crit. Care. 27:314.e1-11.
4. Matsuda K, Hirasawa H, Oda S, Shiga H, Nakanishi K. (2001) Current topics on cytokine removal technologies. Ther. Apher. 5:306-14.
5. Kellum JA, Venkataraman R. (2002) Blood purification in sepsis: an idea whose time has come? Crit. Care Med. 30:1387-8.
6. Kellum JA, Song M, Venkataraman R. (2004) Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit. Care Med. 32:801-5.
7. Venkataraman R, Subramanian S, Kellum JA. (2003) Clinical review: extracorporeal blood purification in severe sepsis. Crit. Care. 7:139-45.
8. Peng ZY, Carter MJ, Kellum JA. (2008) Effects of hemoadsorption on cytokine removal and shortterm survival in septic rats. Crit. Care Med. 36:1573-7.
9. Schroder M, von LE, Hubbuch J. (2006) Direct quantification of intraparticle protein diffusion in chromatographic media. J. Phys. Chem. B. 110:1429-36.
10. Ahrenholz DH, Simmons RL. (1980) Fibrin in peritonitis. I. Beneficial and adverse effects of fibrin in experimental E. coli peritonitis. Surgery. 88:41-7.
11. Hau T, Simmons RL. (1980) Chemotactic substances in the treatment of experimental intraperitoneal infections. Ann. Surg. 192:625-8.
12. Mi Q, et al. (2011) A dynamic view of trauma/hemorrhage-induced inflammation in mice: principal drivers and networks. PLoS One. 6:e19424.
13. Secher T, et al. (2009) Crucial role of TNF receptors 1 and 2 in the control of polymicrobial sepsis. J. Immunol. 182:7855-64.
14. Alves-Filho JC, et al. (2009) Regulation of chemo - kine receptor by toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc. Natl. Acad. Sci. U. S. A. 106:4018-23.
15. Spite M, et al. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature. 461:1287-91.
16. Monserrat J, et al. (2009) Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit. Care. 13:R26.
17. Call DR, et al. (2001) Ratio of local to systemic chemokine concentrations regulates neutrophil recruitment. Am. J. Pathol. 158:715-21.
18. Bone RC. (1996) Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 125:680-7.
19. Boujoukos AJ, Martich GD, Supinski E, Suffredini AF. (1993) Compartmentalization of the acute cytokine response in humans after intravenous endotoxin administration. J. Appl. Physiol. 74:3027-33.
20. Schein M, Wittmann DH, Holzheimer R, Condon RE. (1996) Hypothesis: compartmentalization of cytokines in intraabdominal infection [review]. Surgery. 119:694-700.
21. Molina PE, Bagby GJ, Stahls P. (2001) Hemorrhage alters neuroendocrine, hemodynamic, and compartment-specific TNF responses to LPS. Shock. 16:459-65.
22. Cavaillon JM, Annane D. (2006) Compartmentalization of the inflammatory response in sepsis and SIRS. J. Endotoxin Res. 12:151-70.
23. An G, Nieman G, Vodovotz Y. (2012) Computational and systems biology in trauma and sepsis: current state and future perspective. Int. J. Burn Trauma. 1-10.
24. An G, Nieman G, Vodovotz Y. (2012) Toward computational identification of multiscale "tipping points" in acute inflammation and multiple organ failure. Ann. Biomed. Eng. 40:2414-24.
25. Goldie AS, et al. (1995) Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group. JAMA. 274:172-7.
26. van der Poll T, de Waal MR, Coyle SM, Lowry SF. (1997) Antiinflammatory cytokine responses during clinical sepsis and experimental endotoxemia: sequential measurements of plasma soluble interleukin (IL)-1 receptor type II, IL-10, and IL-13. J. Infect. Dis. 175:118-22.
27. Boomer JS, et al. (2011) Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA. 306:2594-605.
28. Novotny AR, et al. (2012) Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology. 217:616-21.
29. Osuchowski MF, Welch K, Siddiqui J, Remick DG. (2006) Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/ CARS continuum in sepsis and predict mortality. J. Immunol. 177:1967-74.
30. Tamayo E, et al. (2011) Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur. Cytokine Netw. 22:82-7.
31. Pinsky MR. (2001) Sepsis: a pro- and antiinflammatory disequilibrium syndrome. Contrib. Nephrol. (132):354-66.
32. Angus DC, et al. (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29:1303-10.
33. Janes KA, Yaffe MB. (2006) Data-driven modelling of signal-transduction networks. Nat. Rev. Mol. Cell. Biol. 7:820-8.
34. Peng ZY, et al. (2012) Acute removal of common sepsis mediators does not explain the effects of extracorporeal blood purification in experimental sepsis. Kidney Int. 81:363-9.
35. Peng Z, et al. (2010) Blood purification in sepsis: a new paradigm. Contrib. Nephrol. 165:322-8.
36. Yekebas EF, et al. (2001) Attenuation of sepsisrelated immunoparalysis by continuous venovenous hemofiltration in experimental porcine pancreatitis. Crit. Care Med. 29:1423-30.
37. Kollef MH, Fraser VJ. (2001) Antibiotic resistance in the intensive care unit. Ann. Intern. Med. 134:298-314.
38. An G, Nieman G, Vodovotz Y. (2012) Computational and systems biology in trauma and sepsis: current state and future perspective. Int. J. Burn Trauma. 2:1-10.